- Report
- May 2025
- 186 Pages
Global
From €3159EUR$3,545USD£2,740GBP
€3510EUR$3,939USD£3,044GBP
- Report
- November 2024
- 150 Pages
Global
From €5302EUR$5,950USD£4,599GBP
- Report
- July 2025
- 175 Pages
Global
From €4001EUR$4,490USD£3,470GBP
- Report
- January 2025
- 175 Pages
Global
From €4001EUR$4,490USD£3,470GBP
- Report
- July 2025
- 152 Pages
Global
From €5213EUR$5,850USD£4,521GBP
- Report
- December 2024
- 150 Pages
Global
From €2896EUR$3,250USD£2,512GBP
€4322EUR$4,850USD£3,748GBP
- Report
- April 2025
- 175 Pages
Global
From €4001EUR$4,490USD£3,470GBP
- Report
- February 2025
- 182 Pages
Global
From €3408EUR$3,825USD£2,956GBP
€4010EUR$4,500USD£3,478GBP
- Report
- May 2025
- 560 Pages
Global
From €4411EUR$4,950USD£3,826GBP
- Report
- January 2025
- 165 Pages
Global
From €4144EUR$4,650USD£3,594GBP
- Report
- January 2025
- 165 Pages
Global
From €2540EUR$2,850USD£2,203GBP
- Report
- May 2025
- 194 Pages
Global
From €3159EUR$3,545USD£2,740GBP
€3510EUR$3,939USD£3,044GBP
- Report
- May 2025
- 183 Pages
Global
From €3159EUR$3,545USD£2,740GBP
€3510EUR$3,939USD£3,044GBP
- Report
- May 2025
- 183 Pages
Global
From €3159EUR$3,545USD£2,740GBP
€3510EUR$3,939USD£3,044GBP
- Report
- May 2025
- 199 Pages
Global
From €3159EUR$3,545USD£2,740GBP
€3510EUR$3,939USD£3,044GBP
- Report
- May 2025
- 187 Pages
Global
From €3159EUR$3,545USD£2,740GBP
€3510EUR$3,939USD£3,044GBP
- Report
- April 2025
- 138 Pages
Global
From €2672EUR$2,999USD£2,318GBP
- Report
- February 2025
- 135 Pages
Global
From €2672EUR$2,999USD£2,318GBP
- Report
- August 2024
- 143 Pages
Global
From €2672EUR$2,999USD£2,318GBP
- Report
- April 2025
- 120 Pages
Global
From €5302EUR$5,950USD£4,599GBP

A diagnostic biomarker is a biological molecule or gene that is used to identify a particular disease or condition. It is used to diagnose, monitor, and predict the progression of a disease or condition. Diagnostic biomarkers are used to detect the presence of a disease or condition, to determine the severity of the disease or condition, and to monitor the effectiveness of treatments. Diagnostic biomarkers are used in a variety of medical fields, including oncology, neurology, cardiology, and infectious diseases.
Diagnostic biomarkers are typically identified through a variety of methods, including genetic sequencing, proteomics, and metabolomics. These methods allow for the identification of biomarkers that are specific to a particular disease or condition.
The diagnostic biomarker market is a rapidly growing field, with many companies developing and marketing diagnostic biomarkers. Companies in this market include Illumina, Thermo Fisher Scientific, Qiagen, Roche, and Agilent Technologies. Show Less Read more